ProEx C stain analysis in recurrent respiratory papillomatosis

Annals of Otology, Rhinology and Laryngology

Volumn 119, Issue 2, 2010, Pages 99-104

  Bhandarkar, Naveen D ^a   Sims, H Steven ^a   David, Odile ^a,b  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^b UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

Dysplasia; Human papillomavirus; Larynx; ProEx C; Recurrent respiratory papillomatosis

Indexed keywords

EOSIN; HEMATOXYLIN;

ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; DYSPLASIA; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LARYNX PAPILLOMATOSIS; PRIORITY JOURNAL; PROEX C STAIN; RECURRENT INFECTION; STAIN;

EID: 77149170853     PISSN: 00034894     EISSN: None     Source Type: Journal    
DOI: 10.1177/000348941011900206     Document Type: Article

References (18)

1. Derkay CS. Recurrent respiratory papillomatosis. Laryngoscope 2001;111:57-69.
2. Wiatrak BJ, Wiatrak DW, Broker TR, Lewis L. Recurrent respiratory papillomatosis: a longitudinal study comparing severity associated with human papilloma viral types 6 and 11 and other risk factors in a large pediatric population. Laryngoscope 2004;114(suppl 104):1-23.
3. Dedo HH, Yu KC. CO(2) laser treatment in 244 patients with respiratory papillomas. Laryngoscope 2001;111:1639-44.
4. Klozar J, Taudy M, Betka J, Kana R. Laryngeal papilloma - precancerous condition? Acta Otolaryngol Suppl 1997; 527:100-2.
5. Shroyer KR, Homer P, Heinz D, Singh M. Validation of a novel immunohistochemical assay for topoisomerase II-alpha and minichromosome maintenance protein 2 expression in cervical cytology. Cancer 2006;108:324-30.
6. Tambouret RH, Misdraji J, Wilbur DC. Longitudinal clinical evaluation of a novel antibody cocktail for detection of high-grade squamous intraepithelial lesions on cervical cytology specimens. Arch Pathol Lab Med 2008;132:918-25.
7. Badr RE, Walts AE, Chung F, Bose S. BD ProEx C: a sensitive and specific marker of HPV-associated squamous lesions of the cervix. Am J Surg Pathol 2008;32:899-906.
8. Siddiqui MT, Hornaman K, Cohen C, Nassar A. ProEx C immunohistochemistry and high-risk human papillomavirus DNA testing in papanicolaou tests with atypical squamous cell (ASC-US) cytology: correlation study with histologic biopsy. Arch Pathol Lab Med 2008;132:1648-52.
9. Walts AE, Bose S. BD ProEx C immunostaining in extra-mammary Paget's disease and perineal melanoma. Mod Pathol 2009;22:246-51.
10. Blumin JH, Handler EB, Simpson CB, Osipov V, Merati AL. Dysplasia in adults with recurrent respiratory papillomatosis: incidence and risk factors. Ann Otol Rhinol Laryngol 2009;118:481-5.
11. Carvalho CM, Huot L, Charlois AL, Khalfallah SA, Chapuis F, Froelich P. Prognostic factors of recurrent respiratory papillomatosis from a registry of 72 patients. Acta Otolaryngol 2009;129:462-70.
12. Go C, Schwartz MR, Donovan DT. Molecular transformation of recurrent respiratory papillomatosis: viral typing and p53 overexpression. Ann Otol Rhinol Laryngol 2003;112:298-302.
13. Rady PL, Schnadig VJ, Weiss RL, Hughes TK, Tyring SK. Malignant transformation of recurrent respiratory papillomatosis associated with integrated human papillomavirus type 11 DNA and mutation of p53. Laryngoscope 1998;108:735-40.
14. Lele SM, Pou AM, Ventura K, Gatalica Z, Payne D. Molecular events in the progression of recurrent respiratory papillomatosis to carcinoma. Arch Pathol Lab Med 2002;126:1184-8.
15. Sengiz S, Pabuççuoǧlu U, Sarioǧlu S. Immunohistological comparison of the World Health Organization (WHO) and Ljubljana classifications on the grading of preneoplastic lesions of the larynx. Pathol Res Prac 2004;200:181-8.
16. Altieri DC. Survivin in apoptosis control and cell cycle regulation in cancer. Prog Cell Cycle Res 2003;5:447-52.
17. Poetker DM, Sandler AD, Scott DL, Smith RJ, Bauman NM. Survivin expression in juvenile-onset recurrent respiratory papillomatosis. Ann Otol Rhinol Laryngol 2002;111:957-61.
18. Petro BJ, Tan RC, Tyner AL, Lingen MW, Watanabe K. Differential expression of the non-receptor tyrosine kinase BRK in oral squamous carcinoma and normal oral epithelium. Oral Oncol 2004;40:1040-7.